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background:  Recent reports have provided findings that severe salt restriction may be harmful in acute decompensated heart failure (ADHF). 
We have reported that salt supplementation enhances diuretic effects in ADHF, which could avoid administration of high doses of diuretics. The aim 
of this study is to investigate effects of salt supplementation and low-dose furosemide on changes of neurohumoral factors and urinary volume in 
treatment of ADHF.
methods:  Forty four patients were randomly administered either continuous intravenous infusion of 500 mL of 1.7% NaCl supplemented with 40 
mg/day of furosemide (salt infusion group) or continuous intravenous infusion of 500 mL of 5% glucose supplemented with furosemide 40 mg/day 
(glucose infusion group). Venous blood samples were collected to measure plasma electrolytes, plasma renin activity, plasma aldosterone, plasma 
norepinephrine, plasma anti-diuretic hormone and NT-proBNP at baseline and 24 hours after initiation of the treatment. The total 24 hours urinary 
volume was measured and urinalysis was performed.
results:  Urinary volume was greater in the salt infusion group than in the glucose infusion group [salt infusion: 2701 ± 920mL ; glucose 
infusion: 1777 ± 797mL, p<0.001]. Creatinine clearance rate was significantly greater in the salt infusion group than in the glucose infusion group 
[salt infusion: 63.5 ± 52.6mL/min/1.73m2 ; glucose infusion: 39.0 ± 26.3mL/min/1.73m2 ; p=0.048]. We assessed respective variation of 
neurohumoral factors (Δ = 24 hours after initiation of the treatment - baseline). Only Δplasma aldosterone was greater in the salt infusion group 
than in the glucose infusion group [salt infusion: -36.9 ± 42.0pg/mL ; glucose infusion: -14.0 ± 32.4pg/mL, p=0.05]. Although urinary volume was 
greater in the salt infusion group than in the glucose infusion group, ΔSerum K level, urine K/Na ratio and TTKG did not differ significantly in both 
groups.
conclusion:  These results suggest that favorable diuresis in salt and low-dose furosemide combination therapy is mediated by inhibition of 
plasma aldosterone. This may ultimately results in improvement of prognosis of heart failure. 
